Patents by Inventor Kelly IBSEN

Kelly IBSEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240130994
    Abstract: Disclosed herein are ionic liquids and deep eutectic liquids for the treatment of diabetes and related diseases including obesity and metabolic disorders.
    Type: Application
    Filed: February 28, 2023
    Publication date: April 25, 2024
    Inventors: Tyler Brown, Kelly IBSEN
  • Publication number: 20240067716
    Abstract: Disclosed herein are compositions comprising ionic liquids and the use thereof for treating conditions or diseases in a subject.
    Type: Application
    Filed: November 3, 2023
    Publication date: February 29, 2024
    Inventors: Tyler BROWN, Kelly IBSEN
  • Publication number: 20230093875
    Abstract: The technology described herein is directed to compositions comprising CAGE and at least one active compound, e.g., for oral or parenteral administration.
    Type: Application
    Filed: June 28, 2022
    Publication date: March 30, 2023
    Applicants: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Samir MITRAGOTRI, Amrita BANERJEE, Tyler Dwight BROWN, Kelly IBSEN, Christian AGATEMOR
  • Publication number: 20230040805
    Abstract: The technology described herein is directed to compositions comprising CAGE and at least one active compound, e.g., for oral or parenteral administration.
    Type: Application
    Filed: June 28, 2022
    Publication date: February 9, 2023
    Applicants: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Samir MITRAGOTRI, Amrita BANERJEE, Tyler Dwight BROWN, Kelly IBSEN, Christian AGATEMOR
  • Patent number: 11446253
    Abstract: The technology described herein is directed to compositions comprising CAGE and at least one active compound, e.g., for oral or parenteral administration.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: September 20, 2022
    Assignees: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Samir Mitragotri, Amrita Banerjee, Tyler Dwight Brown, Kelly Ibsen, Christian Agatemor
  • Publication number: 20200289421
    Abstract: The technology described herein is directed to compositions comprising CAGE and at least one active compound, e.g., for oral or parenteral administration.
    Type: Application
    Filed: November 16, 2018
    Publication date: September 17, 2020
    Applicants: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Samir MITRAGOTRI, Amrita BANERJEE, Tyler BROWN, Kelly IBSEN, Christian AGATEMOR